HCV Elimination in the US Department of Veterans Affairs
Rachel Gonzalez, Angela Park, Vera Yakovchenko, Shari Rogal, Maggie Chartier, Timothy R. Morgan, David Ross – 17 August 2021
Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers
Mansi Arora, James M. Bogenberger, Amro M. Abdelrahman, Jennifer Yonkus, Roberto Alva‐Ruiz, Jennifer L. Leiting, Xianfeng Chen, Pedro Luiz Serrano Uson Junior, Chelsae R. Dumbauld, Alexander T. Baker, Scott I. Gamb, Jan B. Egan, Yumei Zhou, Bolni Marius Nagalo, Nathalie Meurice, Eeva‐Liisa Eskelinen, Marcela A. Salomao, Heidi E. Kosiorek, Esteban Braggio, Michael T. Barrett, Kenneth H. Buetow, Mohamad B. Sonbol, Aaron S. Mansfield, Lewis R. Roberts, Tanios S. Bekaii‐Saab, Daniel H. Ahn, Mark J. Truty, Mitesh J. Borad – 17 August 2021
Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients
Alexandra T. Strauss, Andrew M. Hallett, Brian J. Boyarsky, Michael T. Ou, William A. Werbel, Robin K. Avery, Aaron A. R. Tobian, Allan B. Massie, James P. A. Hamilton, Jacqueline M. Garonzik‐Wang, Dorry L. Segev – 17 August 2021
Paul David Berk, editor extraordinaire and bilirubinologist
James L. Boyer, Allan W. Wolkoff – 16 August 2021
Novel Composite Endpoint for Assessing Outcomes in Liver Transplantation: Arterial and Biliary Complication–Free Survival
Eric Savier, Yann De Rycke, Chetana Lim, Claire Goumard, Geraldine Rousseau, Fabiano Perdigao, Pierre Rufat, Chady Salloum, Laura Llado, Emilio Ramos, Josefina Lopez‐Dominguez, Alba Cachero, Joan Fabregat, Daniel Azoulay, Olivier Scatton – 16 August 2021 – Transplant and patient survival are the validated endpoints to assess the success of liver transplantation (LT). This study evaluates arterial and biliary complication–free survival (ABCFS) as a new metric.
Issue Information
16 August 2021
Treatment of Viral Hepatitis Due to Adenovirus in a Liver Transplantation Recipient: The Clinical Use of Cidofovir and Intravenous Immunoglobulin
Ayman Haq, Alden Gregston, Saleh Elwir, Cedric W. Spak – 16 August 2021
Viral Hepatitis in Pregnancy: An Update on Screening, Diagnosis, and Management
Vedha Sanghi, Christina C. Lindenmeyer – 15 August 2021
Viral Hepatitis in Pregnancy: An Update on Screening, Diagnosis, and Management
Vedha Sanghi, Christina C. Lindenmeyer – 15 August 2021
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
Alberto Zanetto, Elena Campello, Cristiana Bulato, Sabrina Gavasso, Graziella Saggiorato, Sarah Shalaby, Luca Spiezia, Umberto Cillo, Fabio Farinati, Francesco Paolo Russo, Patrizia Burra, Marco Senzolo, Paolo Simioni – 15 August 2021 – In patients with cirrhosis, particularly those with hepatocellular carcinoma (HCC), hypercoagulability may be associated with purported increased risks of portal vein thrombosis and cirrhosis progression.